BioWorld MedTech

Sep. 11, 2015

Funding Breast Imaging Technology: Delphinus raises $39.5M to fuel SoftVue commercialization efforts

A company developing an imaging system for breast cancer screening is getting noticed in the venture capital community. Delphinus Medical Technologies (Plymouth Township, Mich.) has raised $39.5 million in a Series C financing round. Read More

Inside the Beltway: MedPAC backs Linac utilization rate of 70% seen in MPFS draft

Epic going Dutch: Epic Systems goes global with the launch of Dutch electronic medical records

Second Feasibility study Underway: Lumicell receives FDA nod for GI cancer imaging feasibility study

Agreements/contracts: IBM opens Watson Health center with new partners

Buyout on the Mind: Mindray lowers privatization bid to $3.2 billion citing weak financials

Patents: VolitionRx receives patent for epigenetic blood test

HIT Bits: AccentHealth launches digital patient engagement platform

Briefly noted

People in Places

Products

MDD's Diagnostics Extra

Today's news in brief

BioWorld

BioWorld briefs for April 6, 2026.

Hengrui discovers new Nav1.8 blockers

BioWorld Science

Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...

News in brief

BioWorld Asia

BioWorld Asia briefs for April 7, 2026

Hematopoietic stem cell research points to leukemia’s early roots

BioWorld Science

Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...

Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis

BioWorld Science

Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...